Durable response of tislelizumab plus cisplatin, nab-paclitaxel followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A case report

Limited patients with locoregionally advanced nasopharyngeal carcinoma (LA-NPC) have achieved complete response (CR) from induction chemotherapy (IC). Neoadjuvant immunotherapy combined with chemotherapy has marked therapeutic effects in some locoregionally advanced solid tumors. However, its effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Haifeng, Yang, Donghong, Luo, Guoqing, He, Jiaqi, Yi, Guihua, Chen, Zihong, Li, Haiwen, Luo, Qianbing, Huang, Ningxin, Luo, Haiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936014/
https://www.ncbi.nlm.nih.gov/pubmed/36800614
http://dx.doi.org/10.1097/MD.0000000000032924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936014/
https://www.ncbi.nlm.nih.gov/pubmed/36800614
http://dx.doi.org/10.1097/MD.0000000000032924

Ejemplares similares